Medindia
Medindia LOGIN REGISTER
Advertisement

Tianyin Corporate Presentation Updated

Thursday, June 3, 2010 Corporate News
Advertisement
CHENGDU, China, June 3 TianyinPharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company thatspecializes in modernized traditional Chinese medicine and branded genericspublishes the updated corporate presentation at the Company's website:
Advertisement

http://www.tianyinpharma.com

About Tianyin Pharmaceuticals

Tianyin Pharmaceutical Co., Inc., headquartered in Chengdu, SichuanProvince of China, is a leading biopharmaceutical company that is engaged inthe development, manufacturing, marketing and sale of modernized traditionalChinese medicines and branded generics, equipped with two state-of-the-artmanufacturing facilities and an extensive nationwide sales and distributionnetwork throughout China. Tianyin currently manufactures and markets acomprehensive portfolio of 52 products, of which 23 are listed in the highlyselective National Medicine Catalog of the National Medical Insurance program,7 are included in the essential drug list of China. Tianyin achieved 10 newdrug approvals at SFDA in 2009 and has a pipeline of 12 products pendingregulatory approval that target various indications with considerable marketpotential. Tianyin has an extensive nationwide distribution network with asales force of 730 sales representatives out of totaled 1,365 employees. Formore information about Tianyin, please visit http://www.tianyinpharma.com .
Advertisement

Safe Harbor Statement

The Statements which are not historical facts contained in this pressrelease are forward-looking statements that involve certain risks anduncertainties including but not limited to risks associated with theuncertainty of future financial results, additional financing requirements,development of new products, government approval processes, the impact ofcompetitive products or pricing, technological changes, the effect of economicconditions and other uncertainties detailed in the Company's filings with theSecurities and Exchange Commission.For more information, please contact: James Jiayuan Tong M.D. Ph.D. Chief Financial Officer, Chief Business & Development Officer Director Tianyin Pharmaceutical Co., Inc. Web: http://www.tianyinpharma.com Email: [email protected] Tel: +86-28-8551-6696 (Chengdu, China) +1-949-350-6999 (U.S.) +86-134-3655-0011 (China) Address: 23rd Floor Unionsun YangKuo Plaza No 2 Block 3 South Renmin Road Chengdu, 610041 China

SOURCE Tianyin Pharmaceutical Co., Inc.
Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close